Index of reports
> Cases with Vomiting (134)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Methotrexate where reactions include vomiting. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 134 Next >>
Possible Methotrexate side effects in 51 year old female
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: 51 year old female, weighing 53.0 kg (116.6 pounds)
Reactions: Vomiting, Pneumonia, Pain, Joint Dislocation, Urine Odour Abnormal, RIB Fracture, Thoracic Vertebral Fracture, Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Abatacept Subq Injection 125mg / ML
Dosage: next injection on 13aug2012
Indication: Rheumatoid Arthritis
Start date: 2011-12-01
Methotrexate
Prednisone TAB
Dosage: tapered down to 40 mg, 30 mg, 20 mg and to 10 mg. stayed on 10 mg for a couple of months and 5 mg
Possible Methotrexate side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-14
Patient: 65 year old male, weighing 66.0 kg (145.2 pounds)
Reactions: Weight Decreased, Vomiting, Mycobacterium Chelonae Infection, Hyperkalaemia, Hypercreatininaemia, Rectal Haemorrhage, Reticulocyte Count Decreased, Diarrhoea, RED Blood Cell Count Decreased, Megakaryocytes Abnormal, Neutropenia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clarithromycin
Dosage: 500 mg, 2x/day
Start date: 2012-05-31
End date: 2012-06-26
Ketoprofen
Dosage: 100-300 mg, daily
Administration route: Oral
Indication: Juvenile Arthritis
Methotrexate
Dosage: 20 mg, weekly
Administration route: Oral
Indication: Juvenile Arthritis
Prednisone TAB
Dosage: 3 mg, daily
Administration route: Oral
Indication: Juvenile Arthritis
Zyvox
Dosage: 7.8 mg/l, unknown
Start date: 2012-06-28
Zyvox
Dosage: 600 mg, 2x/day
Start date: 2012-05-31
End date: 2012-06-26
Other drugs received by patient: Sertraline; Bisoprolol; Metformin; Tetrazepam; Pantoprazole; Aspegic 1000
Possible Methotrexate side effects in female
Reported by a physician from Japan on 2012-08-13
Patient: female
Reactions: White Blood Cell Count Decreased, Vomiting, Compression Fracture, Platelet Count Decreased, Pancytopenia, Lower Limb Fracture, Decreased Appetite
Drug(s) suspected as cause:
Actemra
Start date: 2009-03-18
End date: 2009-04-01
Actemra
Indication: Rheumatoid Arthritis
Start date: 2009-02-18
End date: 2009-02-18
Methotrexate
Administration route: Oral
Start date: 2009-04-08
End date: 2009-04-10
Methotrexate
Dosage: form reported as peroral agent
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2009-02-04
End date: 2009-03-12
Other drugs received by patient: Loxonin; Prednisolone; Diovan; Rabeprazole Sodium; Folic Acid; Coniel; Amaryl; Alfarol
Possible Methotrexate side effects in 22 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: 22 year old male, weighing 93.1 kg (204.8 pounds)
Reactions: Abdominal Pain, Vomiting, Nausea, Pain, Hyperglycaemia, Unresponsive To Stimuli, Pancytopenia, Disorientation, Pyrexia, Toxicity To Various Agents, Convulsion, Myalgia, Arthralgia, Chest Pain
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Methotrexate
Possible Methotrexate side effects in 55 year old female
Reported by a consumer/non-health professional from United Kingdom on 2012-08-07
Patient: 55 year old female
Reactions: Malaise, Vomiting, Pain, Thyroid Disorder
Drug(s) suspected as cause:
Methotrexate
Possible Methotrexate side effects in female
Reported by a physician from United States on 2012-08-02
Patient: female, weighing 16.9 kg (37.2 pounds)
Reactions: Paronychia, Vomiting, Stomatitis, Pulmonary Alveolar Haemorrhage, Pyrexia, Loss of Consciousness, Mucosal Inflammation, Respiratory Failure, Hypophagia, Rash Maculo-Papular, Diffuse Alveolar Damage, Oesophageal Ulcer, Staphylococcus Test Positive, Pulseless Electrical Activity
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: 1040 mg
Vincristine Sulfate
Dosage: 5 mg
Other drugs received by patient: Bactrim; Zofran; Ceftazidime; Morphine Sulfate
Possible Methotrexate side effects in female
Reported by a consumer/non-health professional from Brazil on 2012-08-01
Patient: female, weighing 77.0 kg (169.4 pounds)
Reactions: Vomiting, Spinal Pain, Flatulence, Neck Mass, Pyrexia, Upper Extremity Mass, Lower Extremity Mass, Malaise, Diarrhoea, Arthralgia, Swelling, Lymph Node Tuberculosis, Dysuria
Drug(s) suspected as cause:
Humira
Indication: Rheumatoid Arthritis
End date: 2011-11-29
Methotrexate
Dosage: 2 tb am, 2 tb pm, on mondays
Start date: 2010-09-01
Methotrexate
Dosage: 4 tablets every monday, once
Indication: Rheumatoid Arthritis
Other drugs received by patient: Meticorten; Tenoxicam; Meticorten; Losartan Potassium; Hydrochlorothiazide
Possible Methotrexate side effects in female
Reported by a physician from Germany on 2012-07-31
Patient: female, weighing 57.0 kg (125.4 pounds)
Reactions: Abdominal Pain, Malaise, Vomiting, General Physical Health Deterioration, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Cytarabine
Methotrexate
Tasigna
Dosage: 400 mg, bid
Administration route: Oral
Start date: 2012-04-16
Tasigna
Dosage: 400 mg, bid
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-14
End date: 2012-04-14
Other drugs received by patient: Acyclovir; Cotrim
Possible Methotrexate side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-27
Patient: female, weighing 56.3 kg (123.9 pounds)
Reactions: Blood Bilirubin Increased, Tachycardia, Disseminated Intravascular Coagulation, Pyrexia, Acidosis, Abdominal Tenderness, Labile Blood Pressure, Hypoxia, Unevaluable Event, Blood Creatinine Increased, Epistaxis, Mouth Haemorrhage, Hypotension, Blood Lactate Dehydrogenase Increased, Encephalopathy, Hyperammonaemia, Sinusitis Fungal, Pulseless Electrical Activity, Hepatic Function Abnormal, Skin Exfoliation, Haemorrhage, Mental Status Changes, Serum Ferritin Increased, Oral Herpes, Weight Increased, Dialysis, Tachypnoea, Dizziness, Drug Clearance Decreased, Fluid Overload, Vomiting, Febrile Neutropenia, Hepatic Enzyme Increased, Renal Impairment, Lower Respiratory Tract Infection Fungal, Diarrhoea, Respiratory Failure, Oliguria, Bradycardia, Hypertension, Cardiac Arrest, Klebsiella Test Positive, Nasal Ulcer, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: 15 mg it, : 290mg x2 iv
Vincristine Sulfate
Dosage: 4 mg iv
Other drugs received by patient: Fluconazole; Amphotericin B; Piperacillin and Tazobactam; Fligrastim; Vancomycin; Valacyclovir Hydrochloride; Dexamethasone; Etoposide
Possible Methotrexate side effects in 53 year old female
Reported by a consumer/non-health professional from Ecuador on 2012-07-20
Patient: 53 year old female
Reactions: Abdominal Pain, Vomiting, Diarrhoea, Dehydration
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Methotrexate
Indication: Rheumatoid Arthritis
Rituximab
Dosage: 2 cycles
Start date: 2011-10-17
End date: 2011-10-31
Rituximab
Dosage: 2 cycles
Indication: Rheumatoid Arthritis
Start date: 2009-01-01
Other drugs received by patient: Vitamin B Complex CAP; Naproxen; Prednisone; Gemfibrozil
Possible Methotrexate side effects in 68 year old female
Reported by a consumer/non-health professional from Australia on 2012-07-18
Patient: 68 year old female, weighing 84.0 kg (184.8 pounds)
Reactions: Vomiting, Photophobia, Headache, Arthritis, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Orencia
Dosage: last inf:04-jun-2012.
Indication: Rheumatoid Arthritis
Start date: 2011-01-24
Prednisolone
Other drugs received by patient: Oxycontin; Amoxicillin; Arava; Nexium; Endep
Possible Methotrexate side effects in
Reported by a physician from United Kingdom on 2012-07-17
Patient:
Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole
Possible Methotrexate side effects in
Reported by a physician from United Kingdom on 2012-07-10
Patient:
Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir
Possible Methotrexate side effects in female
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-07-06
Patient: female
Reactions: Vomiting, Arachnoiditis, Respiratory Failure, Mental Status Changes, Headache, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Methotrexate
Possible Methotrexate side effects in 10 year old female
Reported by a physician from Korea, Democratic People's Republic of on 2012-07-06
Patient: 10 year old female
Reactions: Vomiting, Wernicke's Encephalopathy, Nausea, Malnutrition, Mental Status Changes, Convulsion
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Methotrexate
Other drugs received by patient: Cisplatin; Adriamycin PFS
Possible Methotrexate side effects in
Reported by a physician from United States on 2012-07-05
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Dyspnoea, Stomatitis, Vomiting, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Prednisone
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Prednisone
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Other drugs received by patient: Filgrastim; Unknown Medication; Leucovorin Calcium
Possible Methotrexate side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-02
Patient: female, weighing 16.8 kg (37.0 pounds)
Reactions: Pupillary Reflex Impaired, Vomiting, Stomatitis, Retching, Pain, Cardio-Respiratory Arrest, Diarrhoea, Choking
Drug(s) suspected as cause:
Methotrexate
Other drugs received by patient: Zosyn; Dextrose 5% Normal Saline; Zofran
Possible Methotrexate side effects in male
Reported by a individual with unspecified qualification from United States on 2012-06-28
Patient: male, weighing 99.5 kg (218.9 pounds)
Reactions: Vomiting, Fatigue, Nausea, Blood Triglycerides Increased, Asthenia
Drug(s) suspected as cause:
Methotrexate
Dosage: 570 mg
PEG-L-Asparaginase (K-H)
Dosage: 5600 unit
Vincristine Sulfate
Dosage: 4 mg
Possible Methotrexate side effects in
Reported by a physician from United States on 2012-06-28
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Vomiting, Stomatitis, Dyspnoea, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Respiratory Failure, Diarrhoea, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Rituximab
Dosage: on day 8 from cycle 3 to 7
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim
Possible Methotrexate side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Stomatitis, Vomiting, Dyspnoea, Nausea, Gastrointestinal Toxicity, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim
Possible Methotrexate side effects in 14 year old male
Reported by a individual with unspecified qualification from Japan on 2012-06-25
Patient: 14 year old male
Reactions: Dysphagia, Vomiting, Nausea, Hypophagia, Hearing Impaired, Oesophageal Stenosis
Drug(s) suspected as cause:
Cisplatin
Dosage: 167 mg
Indication: Bone Sarcoma
Doxorubicin HCL
Dosage: 42 mg
Indication: Bone Sarcoma
Etoposide
Dosage: 84 mg
Indication: Bone Sarcoma
Ifosfamide
Dosage: 4200
Indication: Bone Sarcoma
Methotrexate
Dosage: 28 mg
Indication: Bone Sarcoma
Possible Methotrexate side effects in 14 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-22
Patient: 14 year old male
Reactions: Vomiting, Nausea, Hearing Impaired, Oesophageal Stenosis
Drug(s) suspected as cause:
Cisplatin
Indication: Bone Sarcoma
Doxorubicin HCL
Indication: Bone Sarcoma
Etoposide
Dosage: 2,6 courses
Indication: Bone Sarcoma
Ifosfamide
Dosage: inj.2,6 courses.
Indication: Bone Sarcoma
Methotrexate
Possible Methotrexate side effects in 62 year old female
Reported by a physician from Canada on 2012-06-19
Patient: 62 year old female
Reactions: Vomiting, Nausea, Condition Aggravated, Pancytopenia
Drug(s) suspected as cause:
Hydroxychloroquine Sulfate
Indication: Lupus Nephritis
Methotrexate
Administration route: Oral
Indication: Condition Aggravated
Prednisone
Indication: Lupus Nephritis
Possible Methotrexate side effects in 47 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-19
Patient: 47 year old male
Reactions: Mucosal Inflammation, Rash Generalised, Vomiting, Nausea, Pancytopenia, Pyrexia, Toxicity To Various Agents
Drug(s) suspected as cause:
Methotrexate
Possible Methotrexate side effects in 14 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-14
Patient: 14 year old male
Reactions: Vomiting, Nausea, Hearing Impaired, Oesophageal Stenosis
Drug(s) suspected as cause:
Cisplatin
Dosage: 167mg
Indication: Bone Sarcoma
Doxorubicin HCL
Dosage: 42mg
Indication: Bone Sarcoma
Etoposide
Dosage: 84mg
Indication: Bone Sarcoma
Ifosfamide
Dosage: 4200mg
Indication: Bone Sarcoma
Methotrexate
Dosage: 28mg
Indication: Bone Sarcoma
Possible Methotrexate side effects in 14 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-14
Patient: 14 year old male
Reactions: Vomiting, Nausea, Hearing Impaired, Oesophageal Stenosis
Drug(s) suspected as cause:
Cisplatin
Dosage: 167mg
Indication: Bone Sarcoma
Doxorubicin HCL
Dosage: 42mg
Indication: Bone Sarcoma
Etoposide
Dosage: 84mg
Indication: Bone Sarcoma
Ifosfamide
Dosage: 4200mg
Indication: Bone Sarcoma
Methotrexate
Dosage: 28mg
Indication: Bone Sarcoma
Possible Methotrexate side effects in 14 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-14
Patient: 14 year old male
Reactions: Vomiting, Nausea, Hearing Impaired, Oesophageal Stenosis
Drug(s) suspected as cause:
Cisplatin
Dosage: 167mg
Indication: Bone Sarcoma
Doxorubicin HCL
Dosage: 42mg
Indication: Bone Sarcoma
Etoposide
Dosage: 84mg
Indication: Bone Sarcoma
Ifosfamide
Dosage: 4200mg
Indication: Bone Sarcoma
Methotrexate
Dosage: 28mg
Indication: Bone Sarcoma
Possible Methotrexate side effects in male
Reported by a physician from United States on 2012-06-12
Patient: male, weighing 14.6 kg (32.1 pounds)
Reactions: Large Intestine Perforation, Vomiting, Dehydration, Pancytopenia, Pyrexia, Asthenia, Abdominal Tenderness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: total dose administered 70 mg
Dexamethasone
Dosage: total dose administered 80 mg
Methotrexate
Dosage: total dose administered 12 mg
PEG-L-Asparaginase (Pegaspargase, Oncospar)
Dosage: total dose administered 1550 unit
Vincristine
Dosage: total dose administered 2.76 mg
Possible Methotrexate side effects in male
Reported by a physician from United States on 2012-06-12
Patient: male, weighing 72.6 kg (159.8 pounds)
Reactions: Abdominal Pain, Vomiting, Stomatitis, Drug Ineffective, Retching, Gastrointestinal Disorder, Unevaluable Event, Muscle Spasms
Drug(s) suspected as cause:
Humira
Indication: Ankylosing Spondylitis
Start date: 2008-01-01
End date: 2008-01-01
Humira
Start date: 2011-07-01
Humira
Start date: 2008-01-01
End date: 2011-07-01
Humira
Dosage: 40mg qow then 40 mg qweekly
Start date: 2011-11-08
End date: 2012-05-08
Methotrexate
Start date: 2011-07-01
Methotrexate
Start date: 2007-01-01
End date: 2007-01-01
Methotrexate
Indication: Ankylosing Spondylitis
Start date: 2000-01-01
End date: 2000-01-01
Other drugs received by patient: Niacin; Wellbutrin; Flexeril; Remeron; Lisinopril; Meloxicam; Simvastatin; Folic Acid; Lisinopril; Prednisone; Aspirin
Possible Methotrexate side effects in 14 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-11
Patient: 14 year old male
Reactions: Dysphagia, Vomiting, Nausea, Oesophageal Stenosis
Drug(s) suspected as cause:
Cisplatin
Dosage: 167 mg, unk
Indication: Bone Sarcoma
Doxorubicin HCL
Dosage: 42 mg, unk
Indication: Bone Sarcoma
Etoposide
Dosage: 84 mg, unk
Indication: Bone Sarcoma
Ifosfamide
Dosage: 4200 mg, unk
Indication: Bone Sarcoma
Methotrexate
Dosage: 28 mg, unk
Indication: Bone Sarcoma
Page 1 Next >>
|